EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Melatonin and Its Metabolites Can Serve as Agonists on the Aryl Hydrocarbon Receptor and Peroxisome Proliferator-Activated Receptor Gamma

Andrzej T Slominski iD, Tae-Kang Kim iD, Radomir M Slominski, Yuwei Song, Shariq Qayyum iD, Wojciech Placha, Zorica Janjetovic, Konrad Kleszczyński iD, Venkatram Atigadda, Yuhua Song, Chander Raman, Cornelis J Elferink iD und 3 weitere

International Journal of Molecular Sciences · 23.10.2023 · 24 (20) · 15496

DOI: 10.3390/ijms242015496 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 23.10.2023. Verfasst von Andrzej T Slominski und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, University of Alabama at Birmingham, Birmingham, AL 35294, USA. Hauptthemen laut MEDLINE: Melatonin, Receptors, Aryl Hydrocarbon. Die Arbeit wurde bisher 66-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, NCI NIH HHS, NIAMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Melatonin is widely present in Nature. It has pleiotropic activities, in part mediated by interactions with high-affinity G-protein-coupled melatonin type 1 and 2 (MT1 and MT2) receptors or under extreme conditions, e.g., ischemia/reperfusion. In pharmacological concentrations, it is given to counteract the massive damage caused by MT1- and MT2-independent mechanisms. The aryl hydrocarbon receptor (AhR) is a perfect candidate for mediating the latter effects because melatonin has structural similarity to its natural ligands, including tryptophan metabolites and indolic compounds. Using a cell-based Human AhR Reporter Assay System, we demonstrated that melatonin and its indolic and kynuric metabolites act as agonists on the AhR with EC50’s between 10−4 and 10−6 M. This was further validated via the stimulation of the transcriptional activation of the CYP1A1 promoter. Furthermore, melatonin and its metabolites stimulated AhR translocation from the cytoplasm to the nucleus in human keratinocytes, as demonstrated by ImageStream II cytometry and Western blot (WB) analyses of cytoplasmic and nuclear fractions of human keratinocytes. These functional analyses are supported by in silico analyses. We also investigated the peroxisome proliferator-activated receptor (PPAR)γ as a potential target for melatonin and metabolites bioregulation. The binding studies using a TR-TFRET kit to assay the interaction of the ligand with the ligand-binding domain (LBD) of the PPARγ showed agonistic activities of melatonin, 6-hydroxymelatonin and N-acetyl-N-formyl-5-methoxykynuramine with EC50’s in the 10−4 M range showing significantly lower affinities that those of rosiglitazone, e.g., a 10−8 M range. These interactions were substantiated by stimulation of the luciferase activity of the construct containing PPARE by melatonin and its metabolites at 10−4 M. As confirmed by the functional assays, binding mode predictions using a homology model of the AhR and a crystal structure of the PPARγ suggest that melatonin and its metabolites, including 6-hydroxymelatonin, 5-methoxytryptamine and N-acetyl-N-formyl-5-methoxykynuramine, are excellent candidates to act on the AhR and PPARγ with docking scores comparable to their corresponding natural ligands. Melatonin and its metabolites were modeled into the same ligand-binding pockets (LBDs) as their natural ligands. Thus, functional assays supported by molecular modeling have shown that melatonin and its indolic and kynuric metabolites can act as agonists on the AhR and they can interact with the PPARγ at high concentrations. This provides a mechanistic explanation for previously reported cytoprotective actions of melatonin and its metabolites that require high local concentrations of the ligands to reduce cellular damage under elevated oxidative stress conditions. It also identifies these compounds as therapeutic agents to be used at pharmacological doses in the prevention or therapy of skin diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelatoninReceptors, Aryl HydrocarbonHumansKeratinocytesLigandsPPAR gammaBasic Helix-Loop-Helix Proteins

Stichwörter der Autor:innen

AhRPPARγmelatoninmelatonin metabolitesmodelingreceptors

Substanzen

LigandsMelatoninPPAR gammaReceptors, Aryl HydrocarbonPPARG protein, humanAHR protein, humanBasic Helix-Loop-Helix Proteins

Autor:innen und Institutionen

  • Department of Dermatology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
  • Department of Genetics, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
  • Department of Biomedical Informatics and Data Science, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
  • Brigham's Women's Hospital, Harvard University, Boston, MA 02115, USA.
  • Department of Medicinal Biochemistry, Collegium Medicum, Jagiellonian University, 31-008 Kraków, Poland.
  • Department of Dermatology, University of Münster, Von-Esmarch-Str. 58, 48161 Münster, Germany.

ORCID-Profile: Andrzej T Slominski, Tae-Kang Kim, Shariq Qayyum, Konrad Kleszczyński, Cornelis J Elferink, Russel J Reiter

Förderung

  • NIA NIH HHS
  • NCI NIH HHS
  • NIAMS NIH HHS
  • VA
  • BLRD VA
  • NIAID NIH HHS
  • NIEHS NIH HHS
  • Intramural NIH HHS

Zitieren

APA

Slominski, A. T., Kim, T. K., Slominski, R. M., Song, Y., Qayyum, S., Placha, W., Janjetovic, Z., Kleszczyński, K., Atigadda, V., Song, Y., Raman, C., Elferink, C. J., Hobrath, J. V., Jetten, A. M., & Reiter, R. J. (2023). Melatonin and Its Metabolites Can Serve as Agonists on the Aryl Hydrocarbon Receptor and Peroxisome Proliferator-Activated Receptor Gamma. International Journal of Molecular Sciences, 24(20), 15496. https://doi.org/10.3390/ijms242015496

Vancouver

Slominski AT, Kim TK, Slominski RM, Song Y, Qayyum S, Placha W, et al. Melatonin and Its Metabolites Can Serve as Agonists on the Aryl Hydrocarbon Receptor and Peroxisome Proliferator-Activated Receptor Gamma. International Journal of Molecular Sciences. 2023;24(20):15496. doi:10.3390/ijms242015496

BibTeX
@article{Slominski2023,
  author = {Slominski, Andrzej T and Kim, Tae-Kang and Slominski, Radomir M and Song, Yuwei and Qayyum, Shariq and Placha, Wojciech and Janjetovic, Zorica and Kleszczyński, Konrad and Atigadda, Venkatram and Song, Yuhua and Raman, Chander and Elferink, Cornelis J and Hobrath, Judith Varady and Jetten, Anton M and Reiter, Russel J},
  title = {Melatonin and Its Metabolites Can Serve as Agonists on the Aryl Hydrocarbon Receptor and Peroxisome Proliferator-Activated Receptor Gamma},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {20},
  pages = {15496},
  doi = {10.3390/ijms242015496}
}
Kostenlos starten →